{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T15:05:07Z","timestamp":1790175907762,"version":"4.1.0"},"reference-count":70,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Consejo Nacional de Ciencia y Tecnolog\u00eda (CONACyT)","award":["129381"],"award-info":[{"award-number":["129381"]}]},{"name":"Secretar\u00eda de Investigaci\u00f3n y Posgrado, Universidad Aut\u00f3noma de Tlaxcala"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Behavioural Brain Research"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1016\/j.bbr.2014.06.012","type":"journal-article","created":{"date-parts":[[2014,6,13]],"date-time":"2014-06-13T06:19:54Z","timestamp":1402640394000},"page":"203-211","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Clozapine and glycinamide prevent MK-801-induced deficits in the novel object recognition (NOR) test in the domestic rabbit (Oryctolagus cuniculus)"],"prefix":"10.1016","volume":"271","author":[{"given":"Kurt L.","family":"Hoffman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrique","family":"Basurto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbr.2014.06.012_bib0005","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1176\/ajp.156.10.1646","article-title":"Comparison of ketamine-induced thought disorder in healthy volunteers and thought disorder in schizophrenia","volume":"156","author":"Adler","year":"1999","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.bbr.2014.06.012_bib0010","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0014-2999(00)00645-2","article-title":"Antagonist binding at 5-HT(2A) and 5-HT(2C) receptors in the rabbit: high correlations with the profile for the human receptors","volume":"406","author":"Aloyo","year":"2000","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.bbr.2014.06.012_bib0015","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/2045-5380-1-9","article-title":"Criteria of validity for animal models of psychiatric disorders: focus on anxiety disorders and depression","volume":"1","author":"Belzung","year":"2011","journal-title":"Biol Mood Anxiety Disord"},{"key":"10.1016\/j.bbr.2014.06.012_bib0020","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.lfs.2013.01.022","article-title":"Glycinamide, a glycine pro-drug, induces antinociception by intraperitoneal or oral ingestion in ovariectomized rats","volume":"92","author":"Beyer","year":"2013","journal-title":"Life Sci"},{"key":"10.1016\/j.bbr.2014.06.012_bib0025","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1038\/npp.2010.109","article-title":"Effects of the nitric oxide synthase inhibitor L-NAME on recognition and spatial memory deficits produced by different NMDA receptor antagonists in the rat","volume":"35","author":"Boultakadis","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bbr.2014.06.012_bib0030","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.2147\/NDT.S37485","article-title":"Current approaches to treatments for schizophrenia spectrum disorders, part 1: an overview and medical treatments","volume":"9","author":"Chien","year":"2013","journal-title":"Neuropsychiatr Dis Treat"},{"key":"10.1016\/j.bbr.2014.06.012_bib0035","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/0024-3205(83)90127-3","article-title":"Conversion of orally administered 2-n-pentylamidoacetamide into glycinamide and glycine in the rat brain","volume":"33","author":"Christophe","year":"1983","journal-title":"Life Sci"},{"key":"10.1016\/j.bbr.2014.06.012_bib0040","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.neuro.2007.01.014","article-title":"Extrapolating brain development from experimental species to humans","volume":"28","author":"Clancy","year":"2007","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.bbr.2014.06.012_bib0045","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1038\/npp.2010.163","article-title":"Glutamatergic model psychoses: prediction error, learning, and inference","volume":"36","author":"Corlett","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bbr.2014.06.012_bib0050","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.biopsycho.2008.03.011","article-title":"Reduced novelty-P3 associated with increased behavioral distractibility in schizophrenia","volume":"78","author":"Corti\u00f1as","year":"2008","journal-title":"Biol Psychol"},{"key":"10.1016\/j.bbr.2014.06.012_bib0055","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.bbr.2004.05.016","article-title":"Pre- or post-training administration of NMDA receptor blocker MK-801 impairs object recognition memory in rats","volume":"156","author":"DeLima","year":"2005","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.bbr.2014.06.012_bib0060","first-page":"157","article-title":"A microdialysis study of glycinamide, glycine and other amino acid neurotransmitters in rat frontal cortex and hippocampus after the administration of milacemide, a glycine pro-drug","volume":"354","author":"Doheny","year":"1996","journal-title":"Nauyn Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.bbr.2014.06.012_bib0065","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1176\/appi.ajp.158.11.1818","article-title":"Impaired sensory processing as a basis for object-recognition deficits in schizophrenia","volume":"158","author":"Doniger","year":"2001","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.bbr.2014.06.012_bib0070","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.bbr.2009.12.036","article-title":"One-trial object recognition memory in rats and mice: methodological and theoretical issues","volume":"215","author":"Ennaceur","year":"2010","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.bbr.2014.06.012_bib0075","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1176\/appi.ajp.157.5.826","article-title":"Placebo-controlled trial of glycine added to clozapine in schizophrenia","volume":"157","author":"Evans","year":"2000","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.bbr.2014.06.012_bib0080","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0014-5793(95)01308-3","article-title":"Cloning and characterisation of the rabbit 5-HT1D alpha and 5-HT1D beta receptors","volume":"377","author":"Harwood","year":"1995","journal-title":"FEBS Lett"},{"key":"10.1016\/j.bbr.2014.06.012_bib0085","first-page":"10","article-title":"Glycine transport inhibitors for the treatment of schizophrenia","volume":"4","author":"Hashimoto","year":"2010","journal-title":"Open Med Chem J"},{"key":"10.1016\/j.bbr.2014.06.012_bib0090","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1192\/bjp.169.5.610","article-title":"Double-blind, placebo-controlled, crossover trial of glycine adjuvant therapy for treatment-resistant schizophrenia","volume":"169","author":"Heresco-Levy","year":"1996","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.bbr.2014.06.012_bib0095","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1001\/archpsyc.56.1.29","article-title":"Efficacy of high-dose glycine in the treatment of enduring negative symptoms of schizophrenia","volume":"56","author":"Heresco-Levy","year":"1999","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.bbr.2014.06.012_bib0100","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0006-3223(03)00707-8","article-title":"High-dose glycine added to olanzapine and risperidone for the treatment of schizophrenia","volume":"55","author":"Heresco-Levy","year":"2004","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.bbr.2014.06.012_bib0105","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0920-9964(03)00129-4","article-title":"Comparative effects of glycine and D-cycloserine on persistent negative symptoms of schizophrenia: a retrospective analysis","volume":"66","author":"Heresco-Levy","year":"2004","journal-title":"Schizophrenia Res"},{"key":"10.1016\/j.bbr.2014.06.012_bib0110","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.bbr.2013.04.049","article-title":"One-trial object recognition memory in the domestic rabbit (Oryctolagus cuniculus) is disrupted by NMDA receptor antagonists","volume":"250","author":"Hoffman","year":"2013","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.bbr.2014.06.012_bib0115","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.bbr.2009.10.021","article-title":"Scent marking by the male domestic rabbit (Oryctolagus cuniculus) is stimulated by an object's novelty and its specific visual or tactile characteristics","volume":"207","author":"Hoffman","year":"2009","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.bbr.2014.06.012_bib0120","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1111\/j.1471-4159.1988.tb10566.x","article-title":"Formation of the neurotransmitter glycine from the anticonvulsant milacemide is mediated by brain monoamine oxidase B","volume":"50","author":"Janssens de Varebeke","year":"1988","journal-title":"J Neurochem"},{"key":"10.1016\/j.bbr.2014.06.012_bib0125","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1017\/S1461145701002590","article-title":"Adjunctive high-dose glycine in the treatment of schizophrenia","volume":"4","author":"Javitt","year":"2001","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.bbr.2014.06.012_bib0130","first-page":"468","article-title":"Glycine transport inhibitors for the treatment of schizophrenia: symptom and disease modification","volume":"12","author":"Javitt","year":"2009","journal-title":"Curr Opin Drug Discov Devel"},{"key":"10.1016\/j.bbr.2014.06.012_bib0135","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1146\/annurev.clinpsy.032408.153502","article-title":"When doors of perception close: Bottom-up models of disrupted cogntion in schizophrenia","volume":"5","author":"Javitt","year":"2009","journal-title":"Annu Rev Clin Psychol"},{"key":"10.1016\/j.bbr.2014.06.012_bib0140","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1093\/schbul\/sbs069","article-title":"Has an angel shown the way? Etiological and therapeutic implications of the PCP\/NMDA model of schizophrenia","volume":"38","author":"Javitt","year":"2012","journal-title":"Schiz Bull"},{"key":"10.1016\/j.bbr.2014.06.012_bib0145","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1111\/j.1476-5381.2011.01386.x","article-title":"Animal models of schizophrenia","volume":"164","author":"Jones","year":"2011","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.bbr.2014.06.012_bib0150","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.bbr.2007.07.033","article-title":"D-serine and a glycine transporter inhibitor improve MK-801-induced cognitive deficits in a novel object recognition test in rats","volume":"186","author":"Karasawa","year":"2008","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.bbr.2014.06.012_bib0155","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1001\/archpsyc.1994.03950030035004","article-title":"Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychomimetic, perceptual, cognitive, and neuroendocrine responses","volume":"51","author":"Krystal","year":"1994","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.bbr.2014.06.012_bib0160","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0893-133X(94)00131-I","article-title":"Subanesthetic doses of ketamine stimulate psychosis in schizophrenia","volume":"13","author":"Lahti","year":"1996","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bbr.2014.06.012_bib0165","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0893-133X(01)00243-3","article-title":"Effects of ketamine in normal and schizophrenic volunteers","volume":"25","author":"Lahti","year":"2001","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bbr.2014.06.012_bib0170","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.biopsych.2006.04.005","article-title":"Glycine transporter I inhibitor, N-methylglycine (sarcosine), added to clozapine for the treatment of schizophrenia","volume":"60","author":"Lane","year":"2006","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.bbr.2014.06.012_bib0175","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1001\/archpsyc.62.11.1196","article-title":"Sarcosine or D-serine add-on treatment for acute exacerbation of schizophrenia: a randomized, double-blind, placebo-controlled study","volume":"62","author":"Lane","year":"2005","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.bbr.2014.06.012_bib0180","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1017\/S1461145709990939","article-title":"A randomized, double-blind, placebo-controlled comparison study of sarcosine (N-methyglycine) and D-serine add-on treatment for schizophrenia","volume":"13","author":"Lane","year":"2009","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.bbr.2014.06.012_bib0185","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1177\/0269881107077712","article-title":"Do NMDA receptor antagonist models of schizophrenia predict the clinical efficacy of antipsychotic drugs","volume":"21","author":"Large","year":"2007","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.bbr.2014.06.012_bib0190","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/BF00179039","article-title":"Species differences in presynaptic serotonin autoreceptors: mainly 5-HT1B but possibly in addition 5-HT1D in the rat, 5-HT1D in the rabbit and guinea-pig cortex","volume":"343","author":"Limberger","year":"1991","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.bbr.2014.06.012_bib0195","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.pbb.2011.03.023","article-title":"Glutamate signaling in the pathophysiology and therapy of schizophrenia","volume":"100","author":"Lin","year":"2012","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.bbr.2014.06.012_bib0200","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/S0006-3223(96)00546-X","article-title":"Clozapine blunts N- Methyl-D-Aspartate antagonist-induced psychosis: a study with ketamine","volume":"42","author":"Malhotra","year":"1997","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.bbr.2014.06.012_bib0205","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0893-133X(97)00036-5","article-title":"Ketamine-induced exacerbation of psychotic symptoms and cognitive impairment in neuroleptic-free schizophrenics","volume":"17","author":"Malhotra","year":"1997","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bbr.2014.06.012_bib0210","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1523\/JNEUROSCI.4445-12.2013","article-title":"Neurogenesis continues in the third trimester of pregnancy and is suppressed by premature birth","volume":"33","author":"Malik","year":"2013","journal-title":"J Neurosci"},{"key":"10.1016\/j.bbr.2014.06.012_bib0215","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1080\/13546805.2013.854199","article-title":"Failure to benefit from target novelty during encoding contributes to working memory deficits in schizophrenia","volume":"19","author":"Mayer","year":"2014","journal-title":"Cogn Neuropsychiatry"},{"key":"10.1016\/j.bbr.2014.06.012_bib0220","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s00213-010-2137-8","article-title":"The role of serotonin in the NMDA receptor antagonist models of psychosis and cognitive impairment","volume":"213","author":"Meltzer","year":"2011","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bbr.2014.06.012_bib0225","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.ijpsycho.2005.05.012","article-title":"The Wisconsin card sort test and P300 responses to novel auditory stimuli in schizophrenic patients","volume":"60","author":"Merrin","year":"2006","journal-title":"In J Psychophysiol"},{"key":"10.1016\/j.bbr.2014.06.012_bib0230","doi-asserted-by":"crossref","first-page":"191","DOI":"10.2174\/1568007024606258","article-title":"N-methyl-D-aspartate receptor-coupled glycineB receptors in the pathogenesis and treatment of schizophrenia: a critical review","volume":"1","author":"Millan","year":"2002","journal-title":"Curr Drug Targets CNS Neurol Disord"},{"key":"10.1016\/j.bbr.2014.06.012_bib0235","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.pbb.2011.06.011","article-title":"Effects of olanzapine, sertindole and clozapine on MK-801 induced visual memory deficits in mice","volume":"99","author":"Mutlu","year":"2011","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.bbr.2014.06.012_bib0240","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.neuroscience.2007.07.019","article-title":"Differential effects of the N-methyl-d-aspartate receptor antagonist MK-801 on different stages of object recognition memory in mice","volume":"149","author":"Nilsson","year":"2007","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbr.2014.06.012_bib0245","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/0006-2952(94)90123-6","article-title":"The interactions of milacemide with monoamine oxidase","volume":"47","author":"O\u2019Brian","year":"1994","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.bbr.2014.06.012_bib0250","doi-asserted-by":"crossref","first-page":"e145","DOI":"10.1038\/tp.2012.68","article-title":"NAAG peptidase inhibitors block cognitive deficit induced by MK-801 and motor activation induced by d-amphetamine in animal models of schizophrenia","volume":"2","author":"Olszewski","year":"2012","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.bbr.2014.06.012_bib0255","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1124\/jpet.110.166710","article-title":"Behavioral indices in antipsychotic drug discovery","volume":"333","author":"Porsolt","year":"2010","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.bbr.2014.06.012_bib0260","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1038\/sj.bjp.0702532","article-title":"Differential pharmacology between guinea-pig and the gorilla 5-HT1D receptor as probed with isochromans (5-HT1D selective ligands)","volume":"127","author":"Pregenzer","year":"1999","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.bbr.2014.06.012_bib0265","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1097\/00002826-199008000-00010","article-title":"An open-label trial of milacemide in schizophrenia: an NMDA intervention strategy","volume":"13","author":"Rosse","year":"1990","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.bbr.2014.06.012_bib0270","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1097\/00002826-199106000-00012","article-title":"An NMDA intervention strategy in schizophrenia with low-dose milacemide","volume":"14","author":"Rosse","year":"1991","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.bbr.2014.06.012_bib0275","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/syn.20008","article-title":"Clozapine modulates midbrain dopamine neuron firing via interaction with the NMDA receptor complex","volume":"52","author":"Schwieler","year":"2004","journal-title":"Synapse"},{"key":"10.1016\/j.bbr.2014.06.012_bib0280","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.lfs.2008.05.014","article-title":"Clozapine interacts with the glycine site of the NMDA receptor: electrophysiological studies of dopamine neurons in the rat ventral tegmental area","volume":"83","author":"Schwieler","year":"2008","journal-title":"Life Sci"},{"key":"10.1016\/j.bbr.2014.06.012_bib0285","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/0014-2999(93)90568-3","article-title":"Milacemide effects on the temporal inter-relationship of amino acids and monoamine metabolites in rat cerebrospinal fluid","volume":"230","author":"Semba","year":"1993","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.bbr.2014.06.012_bib0290","doi-asserted-by":"crossref","first-page":"859","DOI":"10.2165\/11586650-000000000-00000","article-title":"Meta-analysis of the efficacy of adjunctive NMDA receptor modulators in chronic schizophrenia","volume":"25","author":"Singh","year":"2011","journal-title":"CNS Drugs"},{"key":"10.1016\/j.bbr.2014.06.012_bib0295","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s00213-007-1047-x","article-title":"Relationship between ketamine-induced psychotic symptoms and NMDA receptor occupancy: a (123)I CNS-1261 SPET study","volume":"197","author":"Stone","year":"2008","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bbr.2014.06.012_bib0300","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.biopsych.2003.09.012","article-title":"Glycine transporter I inhibitor, N-methylglycine (sarcosine), added to antipsychotics for the treatment of schizophrenia","volume":"55","author":"Tsai","year":"2004","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.bbr.2014.06.012_bib0305","doi-asserted-by":"crossref","first-page":"522","DOI":"10.2174\/138161210790361452","article-title":"Strategies to enhance N-methyl-D-aspartate receptor-mediated neurotransmission in schizophrenia, a critical review and meta-analysis","volume":"16","author":"Tsai","year":"2010","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.bbr.2014.06.012_bib0310","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1177\/0269881107077739","article-title":"Perceptual organization in ketamine users: preliminary evidence of deficits on night of drug use but not 3 days later","volume":"21","author":"Ulhass","year":"2007","journal-title":"J Psychopharmacology"},{"key":"10.1016\/j.bbr.2014.06.012_bib0315","doi-asserted-by":"crossref","first-page":"e6445","DOI":"10.1371\/journal.pone.0064545","article-title":"Metabolomics reveals metabolic alterations by intrauterine growth restriction in the fetal rabbit brain","volume":"8","author":"van Vliet","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bbr.2014.06.012_bib0320","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0022-3956(99)00031-X","article-title":"Effects of (S)-ketamine on striatal dopamine: a (11C)raclopride PET study of a model psychosis in humans","volume":"34","author":"Vollenweider","year":"2000","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.bbr.2014.06.012_bib0325","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.schres.2013.10.017","article-title":"Reduced habituation in patients with schizophrenia","volume":"151","author":"Williams","year":"2013","journal-title":"Schizophr Res"},{"key":"10.1016\/j.bbr.2014.06.012_bib0330","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF00427414","article-title":"The validity of animal models of depression","volume":"83","author":"Willner","year":"1984","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bbr.2014.06.012_bib0335","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1017\/S146114570500516X","article-title":"A meta-analysis of neuropsychological change to clozapine, olanzapine, quetiapine, and risperidone in schizophrenia","volume":"8","author":"Woodward","year":"2005","journal-title":"Int J Neurospychopharmacol"},{"key":"10.1016\/j.bbr.2014.06.012_bib0340","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1007\/s11682-008-9022-7","article-title":"Auditory oddball fMRI in schizophrenia: association of negative symptoms with regional hypoactivation to novel distractors","volume":"2","author":"Wolf","year":"2008","journal-title":"Brain Imaging Behav"},{"key":"10.1016\/j.bbr.2014.06.012_bib0345","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1016\/j.neuropharm.2011.06.013","article-title":"Mouse pharmacological models of cognitive disruption relevant to schizophrenia","volume":"62","author":"Young","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbr.2014.06.012_bib0350","first-page":"397","article-title":"Deamination of aliphatic amines by type B monoamine oxidase and semicarbazide-sensitive amine oxidase; pharmacological implications","volume":"41","author":"Yu","year":"1994","journal-title":"J Neural Trans Suppl"}],"container-title":["Behavioural Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432814003866?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432814003866?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,3]],"date-time":"2018-10-03T11:58:39Z","timestamp":1538567919000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166432814003866"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":70,"alternative-id":["S0166432814003866"],"URL":"https:\/\/doi.org\/10.1016\/j.bbr.2014.06.012","relation":{},"ISSN":["0166-4328"],"issn-type":[{"value":"0166-4328","type":"print"}],"subject":[],"published":{"date-parts":[[2014,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clozapine and glycinamide prevent MK-801-induced deficits in the novel object recognition (NOR) test in the domestic rabbit (Oryctolagus cuniculus)","name":"articletitle","label":"Article Title"},{"value":"Behavioural Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbr.2014.06.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}